SCHEMBL5933362

SCHEMBL5933362

CC(=O)OCCN(CCOC(C)=O)C(=O)[S]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
CHRM5 P08912 3/20 0.41
CHRM1 P11229 3/20 0.41
CHRM3 P20309 3/20 0.41
CHRM2 P08172 2/20 0.41
CHRM4 P08173 2/20 0.41
CHRNB2 P17787 2/20 0.41
CHRNA4 P43681 2/20 0.41
PGR P06401 1/20 0.41
HTR1A P08908 1/20 0.41
TBXA2R P21731 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA7 P36544 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CHRNA10 Q9GZZ6 1/20 0.41
CHRNA9 Q9UGM1 1/20 0.41
TSHR P16473 1/20 0.41
GALR3 O60755 2/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5932866 0.90 ALDH1A1 (0.43) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL5932153 0.79 ALDH1A1 (0.44) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL5932161 0.79 ALDH1A1 (0.44) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL5932226 0.78 NAAA (0.45) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL5933368 0.77 ALDH1A1 (0.43) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL12671107 0.77 ALDH1A1 (0.43) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL5932870 0.76 MLYCD (0.38) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
SCHEMBL11929073 0.76 ALDH1A1 (0.46) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL7797001 0.76 ALDH1A1 (0.41) ALDH1A1CHRM5CHRM1CHRM3CHRM2
SCHEMBL28964812 0.76 ALDH1A1 (0.45) ALDH1A1CHRM5CHRM1CHRM3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060088786-A1 Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus MITSUI CHEMICALS, INC. (JP) 2006-04-27 US disclosed
EP-1484191-A1 REWRITABLE OPTICAL INFORMATION RECORDING MEDIUM AND RECORDING/REPRODUCING METHOD, RECORDING/REPRODUCING DEVICE Sony Corporation (JP) 2004-12-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060088786-A1 Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus ALPG, TRPC6, GNRHR ALDH1A1 2071/4885CHRM5 214/4885CHRM1 298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.